Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001810406-26-000004
Filing Date
2026-03-18
Accepted
2026-03-18 14:23:35
Documents
3
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 9326
2 EX-24.POA phvs-ex24_poa.htm EX-24.POA 16938
3 GRAPHIC img151619395_0.gif GRAPHIC 13764
  Complete submission text file 0001810406-26-000004.txt   46987
Mailing Address C/O ROCKET PHARMACEUTICALS, INC. 350 FIFTH AVENUE, SUITE 7530 NEW YORK NY 10116
Business Address
Bjork Elisabeth (Reporting) CIK: 0001810406 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40010 | Film No.: 26768008

Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands 31 (0)71 203 6410
Pharvaris N.V. (Issuer) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)